Guest guest Posted November 1, 2003 Report Share Posted November 1, 2003 http://www.redflagsweekly.com/yazbak/2003_nov01_2.html REGRESSIVE AUTISM AND MMR VACCINATION By RFD Columnist, F. Edward Yazbak, MD, FAAP. TL Autism Research Falmouth, Massachusetts E-mail: tlautstudy The California Department of Developmental Services (DDS) regularly reports the number of NEW cases accessing services in the State. (5) In 1994, there were 633 new cases of DSM IV autism in California, less than two cases a day. By 1999, the number of new cases had tripled to 1,944. Earlier this year, DDS reported that 3,577 cases had accessed services in the State in 2002 or 10 new cases a day, every day. New cases increased by 97% in the last 4 years and by 31% in the last year, the largest yearly increase ever recorded. Children with autism under age 3 and those with PDD-NOS and Asperger’s Syndrome were not included. The Education Boards in all states have reported increases in their autism rates. The increases in New England in the last ten years are shown in Table III. Table III Ten Year Increase in Autism in New England Schools, Ages 6-21 State 1992-1993 2002-2003 % Increase Connecticut 164 1,754 969 Maine 37 675 1,724 Massachusetts 493 3,193 548 New Hampshire 0 491 Infinite Rhode Island 19 471 2,379 Vermont 6 247 4,017 Source: U.S. DOE, Office of Special Education Programs, Data Analysis System According to the New Jersey Department of Education, there were 514 6-year old students with autism in the state schools in the 2001-2002 school year compared to 14 students aged 21. This suggests an accelerating increase in autism with a larger number of affected younger children starting school each subsequent year. Across the Atlantic, in the English Channel Island of Jersey, the situation is relatively worse. As of October 25, 2003, there were 64 children, mostly boys, with a diagnosis of autistic spectrum disorder in the Island’s schools. Five were older than 16. The Island’s population is around 87,000. The population of New Jersey is around 8.5 million and there are now 4,180 students with autism ages 6-21 in the state. In 1999 in Wakefield, England, the Local Education Authority reported that the number of children with autistic spectrum disorders (ASD) had increased from 5 to 111 in 7 years. In Scotland, according to the Scottish Education Office, the number of children with ASD attending school, increased by 18% between 1998 and 1999 and by 31% between 1999 and 2000. A study of pre-school children from two areas of the West Midlands (UK) by the Department of Public Health and Epidemiology at the University of Birmingham, revealed that cases of childhood autism increased by about 18% yearly between 1991 and 1996 and that cases of autistic spectrum disorders increased even faster. The Autism Research Unit at Sunderland University reported a ten-fold increase in autism in the UK between 1983 and 1999. Kaye also reported a 7-fold increase in childhood autism between 1988 and 1999 in a study published in the British Medical Journal. (See below). According to a May 2002 report from the National Autistic Society, 1 child out of 82 in elementary schools in England carries a diagnosis of autism. The impact of autism on school systems in Canada was also significant. In September 2000, 1,391 students with autism and Pervasive Developmental Disorders (PDD) were registered in the Province of Quebec schools. By September 2002, the number of registered affected children had reached 2,302, a 65.5% increase in two years, the highest ever recorded. The Minister of Labor and Social Affairs in Saudi Arabia stated in an interview with Arab News that there were 42,500 confirmed cases of autism in the Kingdom in 2002 and that “there remained many undiagnosed cases”. The estimated population of Saudi Arabia was 22,757,092 in July 2001, giving an autism- prevalence rate of 1:500 in the total population. Keeping in mind that the group of children under 10 is in all probability the most affected and that boys usually outnumber girls 4 to 1, the prevalence of autism in boys under the age of 10 in Saudi Arabia is probably one of the highest in the world. * * * It was the mother of an English boy who developed regressive autism and gastro-intestinal difficulties after receiving his MMR vaccination who first decided that there might be a link between the vaccine, the regression and the gut problems. She investigated further and found out that an adult gastro-enterologist at the Royal Free Hospital in London named Andrew Wakefield had researched the possible link between viruses and gastro-intestinal diseases. After much insistence, this mother was able to convince Dr. Wakefield to evaluate her son. To everyone’s surprise, Wakefield included, unusual findings in the child’s intestines were noted. More parents with similarly affected children decided to consult Dr. Wakefield and again, the same rather distinctive pathology was identified. In February 1998, Wakefield published his now well-known study of 12 children with regressive autism and similar gut findings in The Lancet: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. He ended his publication by stating: “We have identified a chronic enterocolitis in children that may be related to neuropsychiatric dysfunction. In most cases, onset of symptoms was after measles, mumps, and rubella immunisation. Further investigations are needed to examine this syndrome and its possible relation to this vaccine”. (6) Dr. Wakefield also added that between the time his paper was submitted for publication and the time that it was actually published, 40 more patients had been evaluated of whom 39 had similar intestinal findings. Dr. Wakefield never said that the MMR vaccine caused autism but only advised that others investigate the possible suggested link between the triple vaccine and this recent form of autism. He also advocated the use of single vaccines, safely spaced so as not to burden the child’s immune system, until the question of the MMR is settled once and for all. Dr. Wakefield was never anti-vaccine and has always stressed the importance of measles vaccination of toddlers. His argument is that such vaccination is actually more needed now because the immunity that today’s infants get from their mothers is weaker and of shorter duration because the mothers’ immunity followed vaccination rather than disease. [That is actually the reason why the administration of the measles (MMR) vaccine was advanced from 15 to 12 months of age.] The vaccine authorities in the United Kingdom, afraid that any agreement with Wakefield’s stand may be construed as less “faith” in their triple vaccine decided to play a sinister game of Russian Roulette and refused to provide the monovalent vaccines. The result is that fewer children are being immunized against measles in a country where the risk to infants and children may be increased because of the arrival and transit of thousands of foreign travelers from every continent daily. The fact is that the single antigens should have never been excluded because as clearly stated in “Immunization against Infectious Disease” [Joint Committee on Vaccination and Immunisation 1988”] “ For children whose parents refuse MMR vaccine, single antigen measles will be available.” Many parents are so desirous to protect their children that they are traveling to France, Belgium and Holland or paying substantial fees in clinics in England to obtain the single vaccines. The authorities’ argument that these convinced and concerned parents will not return for subsequent jabs is offensive. Anyway, it is the measles vaccine that is eminently important at the age of 12 to 15 months. Rubella immunity of females is needed during the childbearing years to prevent Congenital Rubella Syndrome and mumps immunity is important in males as they near puberty. Those two diseases are mild in children and the cellular immunity from disease is stronger and longer lasting. The statement by Dr. David Salisbury who is in charge of the vaccination program in the UK that the MMR vaccine offers better protection against the individual diseases than the single antigen vaccines is not supported by evidence, as shown above... Dr. Brent Taylor, head of the Department of Pediatrics and Child Health at the Royal Free and University College Medical School and possibly Dr. Wakefield’s most rabid critic, stated in the Sunday Herald of January 14, 2001 that: “Separate vaccines do not provide good protection for children.” This statement is not correct either. The rigid stand of the vaccine authorities in the UK that it must be “the MMR or Nothing” will lead to measles outbreaks in a country where thousands of travelers arrive or transit daily. For the parents who remain concerned about the MMR vaccine, but cannot afford the fees charged by private clinics, the choice will unfortunately be “nothing”. The authorities should not try to blame Andrew Wakefield; He only advocated that the single vaccines be made available alongside the MMR. “Nothing” was never one of his options. Dr. Simon Murch should have noted that in his October 31, 2003 letter to the Lancet. The reaction to Dr. Wakefield’s publication was immediate and relentless. Almost five years later, not a day passes without someone somewhere repeating that Wakefield’s study cannot possibly be relevant because it only included 12 patients and it was never duplicated. No one obviously cares to mention that Leo Kanner, only reported on 11 cases when he described a new disease he called infantile autism 60 years ago. As for duplicating Wakefield’s work, after witnessing what has happened to him, rare are the physicians willing to sacrifice their careers in order to investigate this particular aspect of the disease. Arthur Krigsman, MD an American pediatric gastro-enterologist had the courage to do just that. He examined some 200 children with regressive autism and gastro-intestinal symptoms and described the same histo-pathological findings that Wakefield had reported. Unfortunately, his hospital would not allow him to proceed further and test the biopsies for the presence of measles. David Weldon, MD, U.S. Representative to Congress from Florida’s District 15, and a member of the House Committee on Government Reform, discussed the situation at a meeting of the Committee on December 10, 2002. He also requested from Dr. Stephen Foote, of the National Institutes of Health (NIH), to research the matter and to find a way to test the specimens, adding that this could finally prove or disprove the Wakefield hypothesis. Foote said he would do that. As yet, nothing has been reported. In September 2000, Wakefield published a follow-up study of 60 more patients with “autistic entero-colitis” in the American Journal of Gastro-enterology (7) This study is almost never mentioned by the vaccine authorities and lobby, neither is the editorial by Eamonn, Quigley and Hurley in the same issue, (8) which ended with the statement: “Wakefield et al. are to be congratulated on opening yet another window onto the ever-broadening spectrum of gut-brain interactions. Their findings raise many challenging questions that should provoke further much-needed research in this area, research that may provide true grounds for optimism for affected patients and their families” Dr,.Wakefield has now fully investigated many more cases and has authored or co-authored 32 peer-reviewed publications in distinguished journals on related subjects. They are rarely if ever mentioned by his critics. Neither are the 35 studies he published before 1998, and which earlier had been very well received. Two of his recent studies (2002) have explored other aspects of regressive autism. In an original research paper published in Molecular Psychiatry (9) he reported that specific intestinal findings suggesting an autoimmune etiology were found in 23 of 25 children with autism, but not in the controls: 11 children with celiac disease, 5 with cerebral palsy and mental retardation, and 18 normal children. “ A novel form of enteropathy” is now occurring in children with autism”. In another review article (10), Dr. Wakefield described in depth how the inflamed intestine of children with regressive autism might lead to damage to the developing brain. He compared the process with another well-known gut-brain interaction, hepatic encephalopathy, in which confusion, coma and death occur when the failing liver is unable to remove toxins derived from food and bacteria in the intestines. In the summary, Wakefield adds: “For many years it has been suggested that morphine-like peptides & shy;fragments of partially digested protein derived from cow’s milk and cereals - are toxins that play a role in the development of autism. Similar “opioid” molecules appear to play an important role in the toxicity associated with severe liver damage. Thus the parallels between these two conditions, including the treatment approaches for both - relief of constipation, dietary restriction, de-contamination of the intestinal system, and nutritional supplementation & shy; indicate strongly that some forms of autism and intestinal disease are linked.” Clearly, understanding the gut-brain interaction in children with regressive autism will help solve the mystery surrounding it, prevent further damage to affected children and make caring for them much easier. Dr. Andrew Wakefield testified on June 19, 2002 at a special meeting of the House Committee On Government Reform, Representative Daniel Burton of Indiana, Chairman. He stated: “The sum of the research by my group and our collaborators, taken together with additional work by independent physicians and scientists in the United States, has now confirmed the following facts: Children with regressive autism and intestinal symptoms have a novel and characteristic inflammatory disease of their intestine. This disease is not found in developmentally normal control children. This disease is entirely consistent with a viral cause. This disease may be the source of toxic damage to the brain. Measles virus has been identified in the diseased intestine in the majority of children with regressive autism studied, precisely where it would be expected if it were the cause of the intestinal disease. These children, who suffer the same pattern of regressive autism and intestinal inflammation, come from many countries, including the US and Ireland, where they have been investigated and biopsied independently. Measles virus has been found in only a small minority of developmentally normal children. The measles virus in the diseased intestine of autistic children is from the vaccine. Children with regressive autism appear to have an abnormal immune response to measles virus These findings are entirely consistent with parental reports that their normally developing child regressed into autism following exposure to MMR vaccine.” Dr. John O’Leary, Professor of Pathology at Trinity College, Dublin and Associates, an independent group of researchers, devised and carried out extensive and meticulous research in order to identify any viral etiology for the pathology described in the Wakefield studies. In 2002, the group reported in the Journal of Molecular Pathology (11) that: · Measles virus genomic RNA was present in 82% of 91 children with autism compared to only 7% of the 70 developmentally normal controls and · That over 95% of positive children had received MMR as the only documented exposure to measles. The authors concluded that measles virus may be an important immunological trigger in the pathogenesis of lymphoid hyperplasia and entero-colitis In a commentary in the same issue of the Journal of Molecular Pathology (12), Morris & Aldulaimi stated in part that: “Epidemiology is a pretty blunt tool and the studies done do not rule out the possibility that there may be risk groups where a real link between MMR and autism/bowel inflammatory conditions exists” and “There is evidence that developmental disorders are associated with a functional disturbance of the brain-gut axis.” On June 16, 2002, Dr. John O’Leary, announced that 12 children with autism from his original study group had been confirmed as having a vaccine strain measles virus, in their gut. They all had received the MMR vaccine. O’Leary’s results confirm the earlier findings by Kawashima and constitute further evidence of a relationship between MMR vaccination and regressive autism. H. Kawashima and Associates, a group of Tokyo University researchers, 14 investigated the presence of measles genomic RNA in peripheral mononuclear cells in 8 patients with Crohn’s disease, 3 with Ulcerative Colitis and 9 with Autistic Entero-colitis. For controls, they examined healthy children and patients with Subacute Sclerosing Panencephalitis (SSPE), Systemic Lupus Erythematosus (SLE), Human Immunodeficiency Virus 1 (HIV-1) a total of eight cases. Using elaborate and critically accurate identification techniques, the Tokyo researchers reported that: “One of eight patients with Crohn’s disease, one of three patients with ulcerative colitis, and three of nine children with autism, were positive. Controls were all negative. The sequences obtained from the patients with Crohn's disease shared the characteristics with wild-strain virus. The sequences obtained from the patients with ulcerative colitis and children with autism were consistent with being vaccine strains. The results were concordant with the exposure history of the patients.” As a side note: Following MMR vaccination, the presence of measles virus from vaccine was confirmed in the brain of a child in Canada (14), in the throat of a child in France (15) and in the urine of a child in Australia (16). While this was happening abroad, V. K. Singh Ph.D. now at the Biotechnology Center, Utah State University, was busy researching in depth the neuro-immuno-pathogenesis of autism by investigating measles, MMR and anti-neuronal antibody titers in children with the disease. On April 6, 2000, at a US House of Representatives Government Reform Committee meeting, Dr. Singh described his findings and stated: “This was probably the first laboratory-based evidence to link measles virus and/or MMR vaccine to autoimmunity in children with autism … autism may be caused by a measles & shy;or MMR vaccine- induced autoimmune response”. Dr. Singh concluded “In summary, the rapidly accumulating evidence strongly implicates autoimmunity in autism, which in many may result from a vaccine injury… the evidence also suggests a MMR vaccine infection …The onset of autism (or autistic regression) post-immunization should no longer be regarded as merely a coincidence with the timing of the vaccinations, as our federal health officials continue to do.” Dr. Singh’s has also reported: 1. Elevated Myelin Basic Protein (MBP) auto-antibody titers in 28 of 32 children with autism who had elevated measles antibodies and in none (0) of the controls. 2. Elevated MMR antibody titers in 59% (16/27) children with Autism Spectral Disorders (ASD) compared to only 10% (2/ 20) of controls. 3. The presence of MBP auto-antibodies in 81% (13/16) of the children with ASD and in none (0) of the controls. Dr. Singh concluded: “Children with ASD were positive for MMR antibodies compared to none (0/92) of the developmentally normal children tested (Controls). “Over 90% of MMR antibody-positive autistic sera were also positive for MBP auto-antibody “suggesting a causal association between MMR and brain auto-immunity in autism”. Drs. Singh, Jensen and Bradstreet presented results of yet another study on “Serological Detection of Measles Virus in Relation to Autoimmunity in Autism” at the 102nd General Meeting of the American Society for Microbiology [salt Lake City, Utah May 19-23, 2002]. § A significant number of children with autism had antibodies to Myelin Basic Protein (MBP) (up to 88% positive) and also antibodies to MMR (up to 65% positive). § Normal children did not harbor these antibodies. § The analysis of paired samples (serum and cerebrospinal fluid) from children with autism revealed a high degree of serological association and correlation between MMR and MBP antibodies. The authors concluded by stating: “In light of the new evidence presented here, we suggest that the MMR vaccine in some cases of autism might cause autoimmunity and it might do so by bringing on an atypical measles infection that does not produce a typical measles rash but manifests neurological symptoms upon immunization”. Last year, Dr. Singh was awarded the 2002 O. Spurgeon English Humanitarian Award. The award honors “leading physicians and scientists who have made major humanitarian contributions to human welfare”. Not surprisingly, funding for Dr. Singh’s research has become scarce lately. Dr. Robin Hansen, of the MIND [Medical Investigation of Neuro-developmental Disorders] Institute at the University of California, Davies has tested “newborn blood spots” of 15 normal children and 15 children with autism for the presence of MBP antibodies. All 30 specimens were negative. Dr. Tina Zecca et al., New Jersey Medical Center (NJMS), Children’s Hospital of NJ, (19) has reported a 3-fold increase in measles titers in 16 children with autism compared to normal controls and added: “Subjectively, parents have stated that their children's developmental milestones deteriorated following MMR vaccination. Neurological sequelae following MMR are widely reported. MMR therefore may play a role in the pathogenesis of autism. The elevated titers of anti-measles antibodies in autistic children may signify a chronic activation of the immune system against this neurotropic virus.” The above studies involved both actual patients and controls. All viral, endoscopic and serological investigations were carefully carried out and all results have always been available for review. NEW WEB MESSAGE BOARDS - JOIN HERE. Alternative Medicine Message Boards.Info http://alternative-medicine-message-boards.info Exclusive Video Premiere - Britney Spears Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.